Participants:18–64 years · 65+ years
Substances:AUTOLOGOUS T-CELLS TRANSDUCED WITH LENTIVIRAL VECTOR ENCODING AN ANTI-SLAMF7 CD28/CD3-ZETA CHIMERIC ANTIGEN RECEPTOR

Contact Research Centre

Cushing's syndrome

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Pancreatic carcinoma

Not recruiting

Registered drug

Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Bronchopulmonary aspergillosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Opelconazole

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Giant cell arteritis

Not recruiting

Registered drug

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Acute graft versus host disease in intestine

Not recruiting

InvestigationalNo placebo

Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Allogeneic Faecal Microbiota, Pooled

Contact Research Centre

Follicular lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Giant cell arteritis

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Prednisolone

Contact Research Centre

Find therapies in clinical trials near you – page 22

446 trials match your criteria

Bladder transitional cell carcinoma

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Prophylaxis of nausea and vomiting

Study on Amisulpride, Dexamethasone Phosphate, and Ondansetron for Preventing Post-Operative Nausea and Vomiting in Children

Plasma cell myeloma

Study on the Safety and Effectiveness of SLAMF7 CAR-T Cells for Patients with Multiple Myeloma

Cushing's syndrome

Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

Pancreatic carcinoma

Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

Bronchopulmonary aspergillosis

Study on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis

Plasma cell myeloma refractory

Study Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma

Giant cell arteritis

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Chronic lymphocytic leukaemia

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Acute graft versus host disease in intestine

Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

Follicular lymphoma

Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma

Giant cell arteritis

Study on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.